---
figid: PMC6858495__nihms-1042549-f0004
figlink: /pmc/articles/PMC6858495/figure/F3/
number: F3
caption: pRB/E2F pathway dysregulation leading to unrestricted CASP3 gene transcription.
  The pRb/E2F pathway regulation of transcription and cell cycle progression. (A)
  The transcriptional activity of E2F is inhibited through binding with pRb with further
  regulation of the pathway via pl6INK4a. (D) In the presence of growth signals, cells
  turn on E2F transcription via CDK4/6 activation, resulting in phosphorylation of
  pRB and E2F translocation to the nucleus, turning on transcription of target genes
  (i.e., CASP3). (C) In cancer cells, the loss of pl6INK4a, pRb, or overexpression
  of CDK4/6 lead to relief of E2F inhibition, resulting in unregulated transcription.
  For a comprehensive review of this pathway in cancer, see  and .
pmcid: PMC6858495
papertitle: 'Procaspase-3 Overexpression in Cancer: A Paradoxical Observation with
  Therapeutic Potential.'
reftext: Matthew W. Boudreau, et al. ACS Chem Biol. ;14(11):2335-2348.
pmc_ranked_result_index: '5629'
pathway_score: 0.9396393
filename: nihms-1042549-f0004.jpg
figtitle: pRB/E2F pathway dysregulation leading to unrestricted CASP3 gene transcription
year: ''
organisms:
- Homo sapiens
ndex: 8cb498b5-def9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6858495__nihms-1042549-f0004.html
  '@type': Dataset
  description: pRB/E2F pathway dysregulation leading to unrestricted CASP3 gene transcription.
    The pRb/E2F pathway regulation of transcription and cell cycle progression. (A)
    The transcriptional activity of E2F is inhibited through binding with pRb with
    further regulation of the pathway via pl6INK4a. (D) In the presence of growth
    signals, cells turn on E2F transcription via CDK4/6 activation, resulting in phosphorylation
    of pRB and E2F translocation to the nucleus, turning on transcription of target
    genes (i.e., CASP3). (C) In cancer cells, the loss of pl6INK4a, pRb, or overexpression
    of CDK4/6 lead to relief of E2F inhibition, resulting in unregulated transcription.
    For a comprehensive review of this pathway in cancer, see  and .
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP3
  - CDK4
  - CDK6
  - CCND1
  - CCND2
  - CCND3
  - E2F7
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F8
  - CDKN2A
genes:
- word: CASP3
  symbol: CASP3
  source: hgnc_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F7
  entrez: '144455'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F1
  entrez: '1869'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F2
  entrez: '1870'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F3
  entrez: '1871'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F4
  entrez: '1874'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F5
  entrez: '1875'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F6
  entrez: '1876'
- word: E2F
  symbol: E2F
  source: bioentities_symbol
  hgnc_symbol: E2F8
  entrez: '79733'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: p16INK4a
  symbol: p16INK4a
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
chemicals: []
diseases: []
figid_alias: PMC6858495__F3
redirect_from: /figures/PMC6858495__F3
figtype: Figure
---
